Wearable Devices Faciliate the Management of AMI Patients
ConditionAcute Myocardial Infarction
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-75
SponsorRenJi Hospital
About this trial
The study will explore the use of wearable technology to consistently monitor patients with acute myocardial infarction (AMI) receiving primary percutaneous coronary intervention (PCI). Parameters such as heart rate, sleep time, physical activity, and blood pressure will be collected and analyzed to characterize the patients and predict clinical outcomes.
Eligibility criteria
Qualifiers
Aged 18-75 years old
Diagnosed with STEMI or NSTEMI (ACC/AHA guidelines)
Half male and half female
Undergo CAG and PCI treatment;
Disqualifiers
People under the age of 18 years old;
Patients who are pregnant/breastfeeding;
Patients who are allergic to the metallic or plastic components of the wearable devices
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov